AQP4 contributes to the development of inflammatory demyelination diseases of the CNS (neuromyelitis optica spectrum disorder [NMOSD] or acute disseminated encephalomyelitis [ADEM]) (24) and promotes brain inflammation in neurodegenerative diseases (25), stroke (26), and other disorders (27). Here, AQP4 is linked to neuromyelitis optica.